Literature DB >> 21901624

Breast cancer subtypes: two decades of journey from cell culture to patients.

Xiangshan Zhao1, Channabasavaiah Basavaraju Gurumurthy, Gautam Malhotra, Sameer Mirza, Shakur Mohibi, Aditya Bele, Meghan G Quinn, Hamid Band, Vimla Band.   

Abstract

Recent molecular profiling has identified six major subtypes of breast cancers that exhibit different survival outcomes for patients. To address the origin of different subtypes of breast cancers, we have now identified, isolated, and immortalized (using hTERT) mammary stem/progenitor cells which maintain their stem/progenitor properties even after immortalization. Our decade long research has shown that these stem/progenitor cells are highly susceptible to oncogenesis. Given the emerging evidence that stem/progenitor cells are precursors of cancers and that distinct subtypes of breast cancer have different survival outcome, these cellular models provide novel tools to understand the oncogenic process leading to various subtypes of breast cancers and for future development of novel therapeutic strategies to treat different subtypes of breast cancers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901624      PMCID: PMC3902662          DOI: 10.1007/978-1-4614-0254-1_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  42 in total

1.  In vitro models of early neoplastic transformation of human mammary epithelial cells.

Authors:  Vimla Band
Journal:  Methods Mol Biol       Date:  2003

2.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Wissam M Abdallah; Jessica M Foley; Kyle W Jackson; Michael F Clarke; Mari J Kawamura; Max S Wicha
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

3.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types.

Authors:  V Band; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator.

Authors:  Musheng Zeng; Ajay Kumar; Gaoyuan Meng; Qingshen Gao; Goberdhan Dimri; David Wazer; Hamid Band; Vimla Band
Journal:  J Biol Chem       Date:  2002-09-15       Impact factor: 5.157

Review 6.  Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.

Authors:  K Münger; M Scheffner; J M Huibregtse; P M Howley
Journal:  Cancer Surv       Date:  1992

Review 7.  Self-renewal of teratocarcinoma and embryonic stem cells.

Authors:  Ian Chambers; Austin Smith
Journal:  Oncogene       Date:  2004-09-20       Impact factor: 9.867

8.  Cancer research. Mutant stem cells may seed cancer.

Authors:  Jean Marx
Journal:  Science       Date:  2003-09-05       Impact factor: 47.728

9.  A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

Authors:  J M Huibregtse; M Scheffner; P M Howley
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.